Clinical Trials Browser

NCT03317743 2026-04-17

Study to Assess the Safety & Tolerability of NOV140101(IDX-1197) in Patients With Advanced Solid Tumors

Phase 1 Completed

32 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT03881488 2026-04-17

Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies

Phase 1 Completed

100 enrolled

DermatologicHead & NeckOther solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Melanoma, Mesothelioma, Neoplasm Metastasis, Small Cell Lung Carcinoma

NCT04375267 2026-04-14

LuPARP

Phase 1 Completed

18 enrolled

EndocrineNETOther solid neoplasmThoracic

Mesothelioma, Thymoma, Neuroendocrine Tumors

NCT04303858 2026-04-01

A Study to Evaluate Safety and Anti-Tumor Activity of Eciskafusp Alfa (RO7284755) Alone or in Combination With Atezolizumab in Participants With Advanced and/or Metastatic Solid Tumors

Phase 1 Completed

189 enrolled

Other solid neoplasm

Solid Tumors

NCT05848466 2026-03-30

Assessment of Safety, Tolerability and Pharmacokinetics With BAT8010 for Injection in Advanced Malignant Solid Tumors Patients

Phase 1 Completed

23 enrolled

Other solid neoplasm

Advanced or Metastatic Solid Tumors

NCT03678350 2026-03-27

Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery

Phase 1 Completed

9 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Pleural Diseases

NCT04380753 2026-03-25

AMG 510 Ethnic Sensitivity Study (CodeBreaK 105).

Phase 1 Completed

12 enrolled 12 charts

Other solid neoplasm

Advanced/Metastatic Solid Tumors With KRAS p.G12C Mutation

NCT02215720 2026-03-20

TORERO

Phase 1 Completed

45 enrolled

Other solid neoplasm

Patients With Advanced or Metastatic Solid Tumors

NCT04158336 2026-03-18

A Study of Azenosertib (ZN-c3) in Participants With Solid Tumors

Phase 1 Completed

274 enrolled

Other solid neoplasm

Solid Tumor

NCT06056024 2026-03-17

A Study to Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and Oesophagus

Phase 1 Completed

47 enrolled

Other solid neoplasm

Solid Tumor, KRAS Mutation

NCT04261413 2026-03-11

Phase Ia/Ib Study of RS-0139 in Patients With a Recurrent, Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

16 enrolled

Other solid neoplasm

Solid Tumors

NCT05735366 2026-03-10

A Phase 1 Study of SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

22 enrolled

Other solid neoplasm

Solid Tumor

NCT02617277 2026-03-04

Safety, Tolerability and Pharmacokinetics of AZD1775 (Adavosertib) Plus MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumours

Phase 1 Completed

56 enrolled

Other solid neoplasm

Advanced Solid Tumours

NCT05800964 2026-02-17

Study to Explore the Safety, Tolerability, and Pharmacokinetics of AMG 305 in Subjects With Advanced Solid Tumors

Phase 1 Completed

37 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT02122913 2026-02-05

A Study to Test the Safety of the Investigational Drug Larotrectinib in Adults That May Treat Cancer

Phase 1 Completed

75 enrolled 5 FDA

Other solid neoplasm

Solid Tumors Harboring NTRK Fusion

NCT05478486 2026-02-04

Assessment of Safety, Tolerability and PK Profile of MSP008-22 in Patients With Advanced Solid Tumours

Phase 1 Completed

7 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT05372367 2026-02-03

A Study in People With Advanced Cancer to Test Whether the Amount of BI 907828 in the Blood is Influenced by Taking an OATP Inhibitor or a CYP3 Inhibitor

Phase 1 Completed

33 enrolled

Other solid neoplasm

Solid Tumors

NCT02856425 2026-01-20

PEMBIB

Phase 1 Completed

196 enrolled

Other solid neoplasm

Patients With Any Advanced Solid Tumors

NCT04587479 2026-01-13

A First-in-Human Study of JAB-8263 in Adult Patients With Advanced Solid Tumors

Phase 1 Completed

41 enrolled

Other solid neoplasm

Solid Tumors, Adult

NCT04501276 2026-01-08

A Phase 1b/2 Study of ADG116, ADG116 Combined With Anti-PD-1 Antibody or Anti-CD137 Antibody in Solid Tumors Patients

Phase 1 Completed

72 enrolled

Other solid neoplasm

Advanced/Metastatic Solid Tumors

NCT03905148 2026-01-07

Study of the Safety and Pharmacokinetics of BGB-283 (Lifirafenib) and PD-0325901 (Mirdametinib) in Participants With Advanced or Refractory Solid Tumors

Phase 1 Completed

91 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT06130722 2026-01-07

First-in-Human, Phase I, Open-label, Multicenter, Dose Escalation Clinical Study

Phase 1 Completed

18 enrolled

Other solid neoplasm

Locally Advanced/Metastatic Solid Tumors

NCT04617314 2026-01-06

A Study of RC108-ADC in Subjects With Advanced Malignant Solid Tumors

Phase 1 Completed

67 enrolled

Other solid neoplasm

Solid Tumor

NCT05378737 2026-01-06

Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8006 for Injection

Phase 1 Completed

216 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT05864573 2026-01-05

Study of ZGGS15 in Patients With Advanced Solid Tumors

Phase 1 Completed

22 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT01282697 2025-12-22

RAPIRI

Phase 1 Completed

42 enrolled

Other solid neoplasm

Refractory Solid Tumors in Children

NCT04936178 2025-12-22

A Study of NB003 in Patients With Advanced Malignancies

Phase 1 Completed

258 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT03388632 2025-12-18

Recombinant Interleukin-15 in Combination With Checkpoint Inhibitors Nivolumab and Ipilimumab in People With Refractory Cancers

Phase 1 Completed

31 enrolled 20 charts

Other solid neoplasm

Metastatic Solid Tumors

NCT05240898 2025-12-18

A Phase 1 Study of RO7623066 Alone and in Combination in Patients With Advanced Solid Tumors

Phase 1 Completed

116 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT05287399 2025-12-18

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC61in Subjects With Advanced Solid Tumors

Phase 1 Completed

18 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT05105971 2025-12-08

Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumor Patients in China

Phase 1 Completed

30 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT05155722 2025-12-08

Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT1308 in Advanced Solid Tumors

Phase 1 Completed

59 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT05387928 2025-12-05

A Study of KL340399 in Patients With Advanced Solid Tumors

Phase 1 Completed

21 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT05549804 2025-12-05

A Study of Intratumoral KL340399 in Patients With Advanced Solid Tumors

Phase 1 Completed

6 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT06001580 2025-11-21

A Study of BR101 Injection Alone in Subjects With Advanced Solid Tumors

Phase 1 Completed

15 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT05322408 2025-11-05

HCW9218 in Select Advanced Solid Tumors

Phase 1 Completed

18 enrolled 17 charts

Other solid neoplasm

Solid Tumor

NCT04362748 2025-10-07

Study of AMG 256 in Adult Subjects With Advanced Solid Tumors

Phase 1 Completed

34 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT05300048 2025-10-06

Combination of Serabelisib and Insulin Suppressing Diet With or Without Nab-paclitaxel in Subjects With Advanced Solid Tumors With PIK3CA Mutations

Phase 1 Completed

34 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT05072106 2025-09-16

Study to Evaluate the Effect of Bosentan on the Pharmacokinetics of Lurbinectedin in Patients With Advanced Solid Tumors

Phase 1 Completed

11 enrolled 26 charts

Other solid neoplasm

Advanced Solid Tumor

NCT05109832 2025-09-16

A Study of Absorption-Distribution-Metabolism-Excretion (ADME) of [14C]IMP4297 to China Healthy Male Subjects

Phase 1 Completed

6 enrolled

Other solid neoplasm

Solid Tumor

NCT05390944 2025-09-16

An BE Study to Compare 10mg & 20mg of IMP4297 Capsules in Healthy Chinese Subjects Under Fasting Condition

Phase 1 Completed

28 enrolled

Other solid neoplasm

Solid Tumor

NCT05391048 2025-09-16

An BE Study to Compare 10mg & 20mg of IMP4297 Capsules in Healthy Chinese Subjects Under Fed Condition

Phase 1 Completed

36 enrolled

Other solid neoplasm

Solid Tumor

NCT05989997 2025-09-16

Phase I Clinical Trial of 68Ga-NOTA-SNA002

Phase 1 Completed

17 enrolled

Other solid neoplasm

Solid Tumor

NCT04446260 2025-09-15

A Study of SHR-A1811 in Subjects With Advanced Malignant Solid Tumors

Phase 1 Completed

396 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT05723640 2025-09-08

The Safety and Dosimetry Study of 177Lu-LNC1004 Injection

Phase 1 Completed

11 enrolled

Other solid neoplasm

Solid Tumor, Unspecified, Adult

NCT05063318 2025-09-02

Clinical Trial of Lurbinectedin (PM01183) in Patients With Advanced Solid Tumors

Phase 1 Completed

14 enrolled 20 charts

Other solid neoplasm

Advanced Solid Tumors

NCT05582850 2025-08-28

EPRAD

Phase 1 Completed

29 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT04047862 2025-08-22

Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors

Phase 1 Completed

446 enrolled 49 charts

Other solid neoplasm

Locally Advanced and Metastatic Solid Tumors

NCT05494918 2025-08-22

First-In-Human Study in Subjects With Advanced or Metastatic Solid Malignant Tumors

Phase 1 Completed

62 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT06372236 2025-08-12

UTAA06 Injection for Treatment of Advanced Malignant Solid Tumors

Phase 1 Completed

10 enrolled

Other neoplasmOther solid neoplasm

Conditions or Focus of Study: B7-H3 Positive Relapsed/Advanced Malignant Solid Tumor